|
2024
|
Invention
|
Radiolabeled compound for use in a method of treating carbonic anhydrase ix positive diseases. Th... |
|
|
G/S
|
Pharmaceutical products, medical and veterinary
preparations; sanitary products for medicine; di... |
|
|
G/S
|
Pharmaceutical products focused on endocrinology, namely, medical preparations for the treatment ... |
|
|
Invention
|
Combination of fabi inhibitor and antibiotic agent. The present invention provides a compound of ... |
|
|
Invention
|
Debio-0123 in combination with temozolomide and radiotherapy for use in treating glioma. Methods ... |
|
|
G/S
|
Pharmaceutical products, medical and veterinary
preparations; medical hygiene products; foodstuf... |
|
2023
|
Invention
|
Iap inhibitors, methods of making the same and uses thereof. The present invention provides compo... |
|
|
Invention
|
Method for separating target molecules or particles from fibrinogen-containing samples including ... |
|
|
G/S
|
Chemicals for use in industry and science Pharmaceutical preparations for the treatment of blood ... |
|
|
Invention
|
Combination product for the treatment of cancer.
Methods of administering a therapeutically effe... |
|
|
Invention
|
Novel composition. A pharmaceutical composition comprising biodegradable polymer microparticles c... |
|
|
Invention
|
Methods of treating small cell lung cancer. Methods of treating small cell lung cancer (SCLC) usi... |
|
|
G/S
|
Pharmaceutical products and substances, namely, poly-lactic-co-glycolic acid (PLGA) formulations ... |
|
|
G/S
|
Pharmaceutical products and substances. Implantable devices for the subcutaneous release of
medi... |
|
2022
|
Invention
|
Cd37-binding molecules immunoconjugates thereof.
Novel anti-cancer agents, including, but not li... |
|
|
Invention
|
Slow release pharmaceutical composition made of microparticles.
Pharmaceutical composition made ... |
|
|
Invention
|
Anti-cd37 immunoconjugate and anti-cd20 antibody combinations.
Methods of administering immunoco... |
|
|
Invention
|
Novel compounds and their use.
The present invention provides compounds of the general formula (... |
|
|
Invention
|
Novel compounds and their use. The present invention provides compounds of the general formula (I... |
|
|
Invention
|
Novel compounds and their use. S. aureus, E. coli, K. pneumoniaeA. baumanniiA. baumannii. Pharmac... |
|
|
G/S
|
Pharmaceutical products, namely, anti-infectives |
|
2021
|
Invention
|
Method for predicting the response of a patient diagnosed with cancer to treatment and/or imaging... |
|
|
Invention
|
Gallium-labeled gastrin analogue and use in a method of imaging cckb-receptor-positive tumors or ... |
|
|
Invention
|
Alisporivir for use in human viral infections.
The present invention concerns alisporivir for us... |
|
|
Invention
|
Alisporivir for use in human viral infections. The present invention concerns alisporivir for use... |
|
|
Invention
|
Radiolabeled gastrin analogue for use in a method of treating and/or imaging cckb receptor positi... |
|
2020
|
Invention
|
Pyrido-azepine compounds and their uses as antibiotics. The present invention provides compounds ... |
|
|
Invention
|
Dosing regimens for treatment of patients with locally advanced squamous cell carcinoma. Methods ... |
|
|
Invention
|
Medicament and use thereof for treating bacterial infections involving biofilm.
The present inve... |
|
|
Invention
|
Medicament and use thereof for treating bacterial infections involving biofilm. The present inven... |
|
|
Invention
|
Afabicin for use for treating bacterial infections involving biofilm. The present invention relat... |
|
|
G/S
|
Produits pharmaceutiques, nommément, produits pharmaceutiques pour le traitement des maladies onc... |
|
|
G/S
|
Pharmaceutical products, namely, pharmaceutical preparations for the treatment of oncology diseases |
|
|
G/S
|
Pharmaceutical products. |
|
|
Invention
|
Sample collection and processing device. A device for separating and concentrating target particl... |
|
|
G/S
|
Produits pharmaceutiques. |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceuticals for use in diagnosing and treating cancers, ... |
|
|
Invention
|
Afabicin formulation, method for making the same and uses thereof.
The present invention provide... |
|
|
Invention
|
Solid formulations of afabicin with histidine. The present invention provides Afabicin-containing... |
|
|
Invention
|
Afabicin formulation, method for making the same. The present invention provides Afabicin-contain... |
|
|
Invention
|
Cd37-binding molecules and immunoconjugates thereof.
Methods of using CD37 agents, including, bu... |
|
|
Invention
|
Combination product for the treatment of cancer. Methods of administering a therapeutically effec... |
|
2019
|
G/S
|
Financial affairs and monetary affairs, namely, financial information, management and analysis se... |
|
|
G/S
|
Financial affairs; monetary affairs; financial investment
services. |
|
|
Invention
|
Combination treatment of hiv infections.
The present invention provides combination therapies fo... |
|
|
Invention
|
Combination treatment of hiv infections. The present invention provides combination therapies for... |
|
|
Invention
|
Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing t... |
|
|
Invention
|
Method for treating cancer in a human patient by administering an anti-cd37 immunoconjugate using... |
|
|
Invention
|
Anti-cd37 immunoconjugate dosing regimens. Methods of administering immunoconjugates that bind to... |
|
|
Invention
|
Dosing regimens for treatment of solid tumors having one or more genetic alterations in fgfr1, fg... |
|
2018
|
Invention
|
Combination anti cancer therapy with an iap antagonist and an anti pd-1 molecule.
Disclosed is t... |
|
|
Invention
|
Combination of an agonist anti-pd-1 antibody with a gnrh agonist or antagonist to treat cancer.
... |
|
|
Invention
|
Cd37-binding molecules and immunoconjugates thereof. Novel anti-cancer agents, including, but not... |
|
2017
|
Invention
|
Methods for improving anti-cd37 immunoconjugate therapy. Methods for identifying and treating pat... |
|
|
G/S
|
Préparations pharmaceutiques utilisées dans le traitement du cancer; Préparation pharmaceutiques ... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for u... |
|
|
G/S
|
Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the ... |
|
2016
|
G/S
|
Pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical prepar... |
|
|
G/S
|
Pharmaceutical preparations for use in the prevention and/or treatment of cancer; pharmaceutical ... |
|
2015
|
G/S
|
Préparations chimiques et biologiques réactives, nommément, réactifs permettant la formation cont... |
|
|
G/S
|
Chemical products for use in industry, in science. Pharmaceutical and veterinary products; sanita... |
|
|
G/S
|
Produits pharmaceutiques, nommément anti-infectieux. |
|
2013
|
G/S
|
Advertising; business management; business administration;
office functions. Scientific and tech... |
|
2009
|
G/S
|
Chemiotherapeutical medicines and medicines that act on the endocrinal functions (including hormo... |
|
2007
|
G/S
|
Gonadotropin releasing hormone (GnRH) agonist analogue for the treatment of sexual deviations in ... |
|
|
G/S
|
Services relating to the operation or management of businesses, business information relating to ... |
|
2002
|
G/S
|
Scientific and industrial research; development of
scientific, biological, medical and pharmaceu... |
|
|
G/S
|
Scientific and industrial research; product development in the scientific, biological, medical an... |
|
|
G/S
|
Pharmaceutical preparations acting on hormone-dependent diseases, in particular in prostate and b... |
|
2001
|
G/S
|
Pharmaceutical preparations, medicines. |
|
1994
|
G/S
|
Scientific and industrial research; development of chemical
and scientific products and material... |
|
1992
|
G/S
|
Pharmaceutical, veterinary and sanitary products; dietetic
substances adapted for medical use, b... |
